Risk factors for a severe form of COVID-19 after allogeneic haematopoietic stem cell transplantation: a Société Francophone de Greffe de Moelle et de Thérapie cellulaire (SFGM-TC) multicentre cohort study
- PMID: 33522598
- PMCID: PMC8013848
- DOI: 10.1111/bjh.17260
Risk factors for a severe form of COVID-19 after allogeneic haematopoietic stem cell transplantation: a Société Francophone de Greffe de Moelle et de Thérapie cellulaire (SFGM-TC) multicentre cohort study
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
References
-
- Gandhi RT, Lynch JB, Del Rio C. Mild or moderate Covid‐19. N Engl J Med. 2020;383:1757–66. - PubMed
-
- Ljungman P, Mikulska M, de la Camara R, Basak GW, Chabannon C, Corbacioglu S, et al. The challenge of COVID‐19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T‐cell therapy. Bone Marrow Transplant. 2020;55:2071–6. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
